Advisor Group Holdings, Inc. Neogenomics Inc Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,817 shares of NEO stock, worth $34,537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,817
Previous 6,525
26.18%
Holding current value
$34,537
Previous $107,000
57.94%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$141 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$102 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$48.2 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$43.3 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$41.2 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $902M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...